858 Therapeutics Competitors and Similar CompaniesClear all
858 Therapeutics's competitors and similar companies include CN Bio and Acellera.
 858 Therapeutics 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule medications that operate on oncology therapeutic targets, such as proteins that govern RNA and the innate immune response. |  CN Bio CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research. | ||
Founding Date | Founding Date 2019 | Founding Date 2008 | Founding Date 2006 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Milton, GB HQ | Locations Stanmore, GB HQ Barcelona, ES |
Employees | Employees 11 | Employees 576% increase | Employees 14 |
Funding | |||
Latest funding round | Latest funding round $ 60m (over 4 years ago) | Latest funding round N/A | Latest funding round $ 54.9k (about 11 years ago) |
Total funding raised | Total funding raised $ 80.1m | Total funding raised $ 11.5m | Total funding raised $ 54.9k |
For sources of this data, please see the company profile
View Company Profiles
CN Bio
HQ
Milton, GB
CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research.
View company